Form 4: Edwards Lifesciences Director Steven R. Loranger Reports Stock Grants

Director Steven R. Loranger reports the acquisition of common stock and restricted stock units in Edwards Lifesciences Corp.

Summary

• On May 8, 2024, Steven R. Loranger, a director of Edwards Lifesciences Corp, acquired 3,055 shares of common stock and 999 restricted stock units.
• These acquisitions were grants under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program.
• The restricted stock units and awards are scheduled to vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
• Following these transactions, Loranger directly owns 60,372 shares of common stock and indirectly owns 15,000 shares through a trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The grant of restricted stock units and awards aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment to the company's success.

Future Outlook

The restricted stock units and awards are scheduled to vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

Industry Context

This filing is a routine disclosure of stock grants to a company director, which is a common practice in publicly traded companies to incentivize and align the interests of directors with shareholders.

Stakeholder Impact

• The stock grants align the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.

Key Dates